Skip to Content

9 3 5213 (Hydrochlorothiazide-Moexipril 12.5 mg / 7.5 mg)

Pill imprint 9 3 5213 has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213
Hydrochlorothiazide and moexipril hydrochloride
Imprint:
9 3 5213
Strength:
12.5 mg / 7.5 mg
Color:
Yellow
Size:
10.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-5213
Inactive Ingredients:
lactose monohydrate
magnesium stearate
povidone k29/32
sodium bicarbonate
polyethylene glycol 3350
polyvinyl alcohol
magnesium silicate
titanium dioxide
FD&C Yellow No. 5
aluminum oxide
FD&C Yellow No. 6

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide